Amarin Corp - ADR
NASDAQ:AMRN 3:59:53 PM EDT
| Market Cap (Intraday) | 1.97B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 250.5 |
| 10-Day MA | $5.52 |
| 50-Day MA | $6.58 |
| 200-Day MA | $5.83 |
Amarin Corp. Plc Stock, NASDAQ:AMRN
77 Sir John Rogerson's Quay, Grand Canal Docklands, Dublin, Dublin 2
United Kingdom
Phone: +353.1.6699020
Number of Employees: 965
Description
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.